Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026
recent articles
SEOUL, SOUTH KOREA, September 8, 2026 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the 2026 World Conference on Lung Cancer (WCLC 2026), to...
Agilent: The FDA-cleared system will strengthen Agilent's support for digital pathology laboratories SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent...
Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/...
Hamamatsu: New FDA clearances expand Hamamatsu's FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ -- Hamamatsu Photonics K.K. today...
Lumea and TreatmentGPS today announced the Alpine Path integration into Lumea’s software. LEHI, UT, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a...
From Leica Biostystems on LinkedIn: We're excited to share the next milestone in our collaboration with Mindpeak bringing powerful AI tools closer to researchers through the Aperio AI Store. Six Mindpeak algorithms are now available on...
































